What are the dosing parameters for metoprolol (metoprolol succinate ER)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metoprolol Succinate ER Dosing Parameters

Formulation and Administration

Metoprolol succinate extended-release (ER) must be dosed once daily, as this is the only formulation proven to reduce mortality in heart failure—metoprolol tartrate (immediate-release) should not be substituted. 1, 2

  • The extended-release formulation delivers metoprolol at a near-constant rate over approximately 20 hours, producing even plasma concentrations over 24 hours without marked peaks and troughs 3
  • A 100 mg metoprolol ER tablet contains 95 mg of metoprolol succinate and provides equivalent beta-blocking activity to 100 mg metoprolol tartrate 4
  • The tablet disintegrates into individual pellets that act as diffusion cells, releasing drug at a relatively constant rate 4

Condition-Specific Dosing

Heart Failure with Reduced Ejection Fraction (HFrEF)

Start at 12.5-25 mg once daily and titrate every 2 weeks to a target dose of 200 mg once daily. 1, 2

  • Initial dose selection: Use 12.5 mg for more severe heart failure or 25 mg for mild-moderate heart failure 1, 2
  • Titration schedule: 12.5 mg → 25 mg → 50 mg → 100 mg → 200 mg once daily, doubling every 2 weeks if tolerated 1, 2
  • Target dose of 200 mg daily achieved a 34% reduction in all-cause mortality in the MERIT-HF trial 1, 5
  • If full target cannot be achieved, aim for at least 50% of target dose (100 mg daily minimum) as dose-response relationships exist for mortality benefit 1
  • Mean dose achieved in clinical trials was 159 mg daily 1, 2

Hypertension

Start at 50 mg once daily and titrate to 50-200 mg once daily, with a maximum dose of 400 mg daily. 1, 2

  • Initial dose: 50 mg once daily 1
  • Usual maintenance range: 50-200 mg once daily 2
  • Maximum dose: 400 mg once daily 1, 2
  • Increase dose gradually every 1-2 weeks if blood pressure control is not achieved 1
  • Target blood pressure: <130/80 mmHg 1

Post-Myocardial Infarction

After initial IV therapy in acute MI, start oral metoprolol at 50 mg every 6 hours for 48 hours, then transition to maintenance dosing. 2

  • Maintenance dose after MI: 100 mg twice daily of immediate-release formulation 2
  • For extended-release formulation, follow heart failure dosing regimen 1

Atrial Fibrillation Rate Control

Start at 50-100 mg once daily and titrate to 50-400 mg once daily based on heart rate response. 1

  • Target resting heart rate: 50-60 beats per minute unless limiting side effects occur 1
  • Monitor heart rate and blood pressure at each visit during titration 1

Frequent PVCs

Start at 50 mg once daily with a maximum daily dose of 400 mg. 1

  • Initial dose: 50 mg once daily 1
  • Maximum dose: 400 mg once daily 1

Monitoring Parameters During Titration

Monitor heart rate, blood pressure, clinical status, and signs of congestion at each visit. 1, 2

  • Heart rate: Target 50-60 bpm; if <50 bpm with worsening symptoms, halve the dose 1, 6
  • Blood pressure: Monitor for symptomatic hypotension (systolic <100 mmHg with symptoms) 1
  • Signs of worsening heart failure: Increased dyspnea, weight gain >1.5-2.0 kg over 2 days, peripheral edema 1, 2
  • Check blood chemistry 1-2 weeks after initiation and 1-2 weeks after final dose titration 6
  • Watch for symptomatic bradycardia, hypotension, fatigue, dizziness, and bronchospasm 1

Absolute Contraindications

Do not initiate metoprolol succinate ER in patients with the following conditions: 1, 2

  • Signs of heart failure, low output state, or decompensated heart failure 1, 2
  • Current or recent (within 4 weeks) heart failure exacerbation requiring hospitalization 2
  • PR interval >0.24 seconds 1, 2
  • Second or third-degree heart block without a functioning pacemaker 1, 2
  • Active asthma or reactive airways disease 1, 2
  • Sinus bradycardia <50 bpm 1
  • Systolic blood pressure <100 mmHg with symptoms 1
  • Cardiogenic shock or increased risk factors (age >70 years, systolic BP <120 mmHg, heart rate >110 bpm or <60 bpm) 1

Managing Adverse Effects During Titration

Worsening Congestion

First double the diuretic dose; only halve the metoprolol dose if increasing diuretic fails. 1, 6

Symptomatic Bradycardia (HR <50 bpm with symptoms)

Reduce metoprolol dose by 50%. 1, 6

Symptomatic Hypotension

First reduce or eliminate vasodilators (nitrates, calcium channel blockers); second, reduce diuretics if no congestion; third, temporarily reduce metoprolol dose by 50%. 6

Marked Fatigue

Halve the metoprolol dose. 6

Critical Warnings

Never abruptly discontinue metoprolol succinate ER—this can cause severe exacerbation of angina, myocardial infarction, ventricular arrhythmias, and a 2.7-fold increased risk of 1-year mortality. 1

  • If discontinuation is necessary, taper by reducing dose by approximately 25-50% every 1-2 weeks under close surveillance 1
  • Monitor for signs of worsening heart failure symptoms during tapering 1
  • If symptoms worsen during tapering, return to previous dose before attempting more gradual taper 1

Special Population Considerations

Women

Consider starting at 50% of standard doses in women, as metoprolol exposure is 50-80% higher in women than men. 1

  • Women may achieve optimal outcomes at 50% of guideline-recommended doses 1
  • For elderly women, 15 mg produces similar drug exposure to 50 mg in healthy young men 1

Elderly Patients (>70 years)

Use caution and start at lower end of dosing range, particularly in acute MI settings where age >70 is a risk factor for cardiogenic shock. 1

References

Guideline

Metoprolol Treatment Protocol for Hypertension and Heart-Related Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metoprolol Succinate Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Beta Blocker Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.